miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8

Acta Biochimica Et Biophysica Sinica
Jieyun ZhangWeijian Guo

Abstract

Tumor metastasis is the main cause of treatment failure and death in patients with late stage of gastric cancer (GC). Studies showed that microRNAs (miRNAs) are important regulators in the process of tumor metastasis. In this study, we used miRNA array analysis to search for metastasis-associated miRNAs in primary and matched metastasis tissues of patients with GC and found that miR-345-5p (miR-345) was significantly higher in primary sites. Decreased expression of miR-345 was observed in GC tissues and cell lines, which was correlated with aggressive stage and grade. Patients with a higher level of miR-345 had a better prognosis. miR-345 could inhibit the migration and spheroid formation abilities in GC cell lines in transwell assay and spheroid formation assay. RNA sequencing and bioinformatics analysis revealed that miR-345 downregulated the epidermal growth factor receptor pathway substrate 8 (EPS8) and its downstream Rac1 signaling. Mechanistically, we confirmed that miR-345 could target EPS8 by directly binding to its 3' untranslated region by luciferase reporter assay. Further rescue assay showed that the ability of miR-345 in inhibiting the migration, stem-like cell phenotype, and epithelial-mesenchymal transition (EMT)...Continue Reading

References

Feb 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·David A CalderwoodMark H Ginsberg
Nov 24, 2004·Nature Cell Biology·Andrea DisanzaGiorgio Scita
May 4, 2005·Cancer Research·Richard I Gregory, Ramin Shiekhattar
Jun 10, 2005·Nature·Jun LuTodd R Golub
Oct 15, 2005·Development·Ines Alvarez-Garcia, Eric A Miska
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Dec 26, 2008·The New England Journal of Medicine·Anne C Chiang, Joan Massagué
Feb 23, 2010·Molecular Cancer·Xiao-Wei ZhangWei-Jian Guo
Apr 3, 2012·World Journal of Gastrointestinal Oncology·Alba RoccoGerardo Nardone
Apr 30, 2013·Cell·Luke A YatesRobert J C Gilbert
Oct 11, 2013·Future Oncology·Yu-Hua LiJing-Wen Du
Jul 17, 2014·Nature Reviews. Molecular Cell Biology·Minju Ha, V Narry Kim
Aug 1, 2015·Journal of Cancer Research and Clinical Oncology·Qi-guang ChenChui-ze Kong
Sep 12, 2015·Cancer Research·Albert C Yeh, Sridhar Ramaswamy
Jan 23, 2016·Nature·Joan Massagué, Anna C Obenauf
Mar 25, 2016·Nature Reviews. Cancer·Patricia S Steeg
Sep 21, 2016·Journal of Hematology & Oncology·Xiaofeng WangWeijian Guo
Feb 10, 2018·Journal of Hematology & Oncology·Su-Jie NiWei-Jian Guo

❮ Previous
Next ❯

Citations

Jun 4, 2021·Frontiers in Oncology·Jiaxin LiangQianjin Liao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.